Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 56
Page 204
... therapeutic efficacy of corticosteroids in decreasing the inflammatory response and activity of IBD . Another important therapeutic study employed antibodies to a4 integrin given to cotton - top tamarins with experimental colitis41 . By ...
... therapeutic efficacy of corticosteroids in decreasing the inflammatory response and activity of IBD . Another important therapeutic study employed antibodies to a4 integrin given to cotton - top tamarins with experimental colitis41 . By ...
Page 318
... therapeutic potential50,51 , n - 3 FATTY ACID SUPPLEMENTS The rationale for use of n - 3 fatty acids in IBD is to divert arachidonic acid metabolites to less inflammatory derivatives . Large doses of fish oil have been shown to reduce ...
... therapeutic potential50,51 , n - 3 FATTY ACID SUPPLEMENTS The rationale for use of n - 3 fatty acids in IBD is to divert arachidonic acid metabolites to less inflammatory derivatives . Large doses of fish oil have been shown to reduce ...
Page 438
... therapeutic benefits of metronidazole , cipro- floxacin , clarithromycin , and a number of antimycobacterial regimens 56.57 . It is ironic that the pharmaceutical industry has invested so many millions of dollars in studies pitting one ...
... therapeutic benefits of metronidazole , cipro- floxacin , clarithromycin , and a number of antimycobacterial regimens 56.57 . It is ironic that the pharmaceutical industry has invested so many millions of dollars in studies pitting one ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis